On December 8, 2025, Smith+Nephew announced its new RISE strategy and financial targets for 2028 at its Capital Markets Day in London. The strategy aims to elevate financial and operational ...

Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and Stryker (SYK). But which of these two companies is the best option for those ...

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

Smith & Nephew (NYSE:SNN) stock rose ~6% on Tuesday after Q4 revenue grew and the company provided FY23 outlook. Q4 revenue grew 1.4% Y/Y to ~$1.37B. Revenue from Orthopaedics segment fell -0.4% Y/Y ...

Smith & Nephew SNATS SNN recently announced the signing of a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device ...

Fintel reports that on December 4, 2025, RBC Capital Markets reiterated coverage of Smith & Nephew plc - Depositary Receipt ...

Smith & Nephew plc has experienced a sharp sell-off following its Q2 numbers, with the stock falling below its 200DMA. SNN is a capital-hungry business that requires significant reinvestment into ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...